Nairobi, Kenya – On May 29, 2025, the Pharmacy and Poisons Board (PPB) Chief Executive Officer, Dr. F. M. Siyoi, joined Health Cabinet Secretary Hon. Aden Duale during the signing of a Memorandum of Understanding (MoU) between the Ministry of Health—through the Social Health Authority (SHA)—and Roche East Africa. This landmark partnership aims to reduce the cost of breast cancer treatment sessions from KES 120,000 to KES 40,000, with no co-payment required from patients, marking a significant milestone in advancing equitable access to cancer care across Kenya.

At the ceremony, Cabinet Secretary Aden Duale reiterated the Ministry’s commitment to delivering quality healthcare and issued a stern warning to those engaged in illegal pharmaceutical practices. He urged the Pharmacy and Poisons Board to intensify routine inspections nationwide to close unauthorized outlets and protect patient safety.

Furthermore, the Cabinet Secretary highlighted the Track and Trace initiative as a crucial tool for enhancing post-market surveillance and eliminating counterfeit medicines from the supply chain. The PPB received commendations for its robust efforts in post-market surveillance, which remain vital to maintaining the integrity of Kenya’s pharmaceutical sector.